SARS-CoV-2 Spike glycoprotein (Ad26.COV2-S) is indicated for:
Population group: both men and women, only adults (18 years old or older)
SARS-CoV-2 Spike glycoprotein (Ad26.COV2-S) is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
SARS-CoV-2 Spike glycoprotein (Ad26.COV2-S) is contraindicated in the following cases: